Valentina Spigoni

781 total citations
25 papers, 582 citations indexed

About

Valentina Spigoni is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Valentina Spigoni has authored 25 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Valentina Spigoni's work include Diabetes Treatment and Management (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Valentina Spigoni is often cited by papers focused on Diabetes Treatment and Management (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Valentina Spigoni collaborates with scholars based in Italy, United Kingdom and Germany. Valentina Spigoni's co-authors include Alessandra Dei, Riccardo C. Bonadonna, Ivana Zavaroni, Eleonora Derlindati, Federica Fantuzzi, Monia Cito, Raffaella Aldigeri, Marco Metra, Diego Ardigò and Luigi Gnudi and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Valentina Spigoni

24 papers receiving 573 citations

Peers

Countries citing papers authored by Valentina Spigoni

Since Specialization

Citations

This map shows the geographic impact of Valentina Spigoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentina Spigoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentina Spigoni more than expected).

Fields of papers citing papers by Valentina Spigoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentina Spigoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentina Spigoni. The network helps show where Valentina Spigoni may publish in the future.

Co-authorship network of co-authors of Valentina Spigoni

This figure shows the co-authorship network connecting the top 25 collaborators of Valentina Spigoni. A scholar is included among the top collaborators of Valentina Spigoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentina Spigoni. Valentina Spigoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hyperglycemia in the diabetic range, but not previous diagnosis of diabetes mellitus, is an independent indicator of poor outcome in patients hospitalized for severe COVID-19 2025 ·Acta Diabetologica ·Alessandra Dei, Raffaella Aldigeri, (unknown), Andrea Ticinesi, Antonio Nouvenne, Beatrice Prati, (unknown), (unknown), (unknown), (unknown), Valentina Spigoni, Federica Fantuzzi, (unknown), Livia Ruffini, Nicola Sverzellati, Tiziana Meschi, Riccardo C. Bonadonna	0
2	Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial 2024 ·Journal of Endocrinological Investigation ·Alessandra Dei, (unknown), Raffaella Aldigeri, Simona Gardini, (unknown), Michele Perini, (unknown), (unknown), Valentina Spigoni, (unknown), (unknown), (unknown), Paolo Caffarra, Riccardo C. Bonadonna	19
3	SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders 2022 ·Cell Biology and Toxicology ·(unknown), Valentina Spigoni, (unknown), (unknown), Riccardo C. Bonadonna, Alessandra Dei	17
4	Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics 2022 ·Cardiovascular Diabetology ·(unknown), Valentina Spigoni, Federica Fantuzzi, Riccardo C. Bonadonna, Alessandra Dei	3
5	Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders 2022 ·Frontiers in Endocrinology ·Valentina Spigoni, (unknown), (unknown), (unknown), (unknown), Marta Maggi, (unknown), Alessandra Dei	24
6	Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project 2020 ·European Journal of Nutrition ·Daniela Martini, Alice Rosi, Michele Tassotti, (unknown), Margherita Dall’Asta, Letizia Bresciani, Federica Fantuzzi, Valentina Spigoni, Raúl Domínguez‐Perles, Donato Angelino, Cristian Ricci, (unknown), Pedro L. Tornel, Francesca Scazzina, Ángel Gil‐Izquierdo, Alessandra Dei, Furio Brighenti, Riccardo C. Bonadonna, Daniele Del Rio, Pedro Mena	12
7	Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events 2020 ·Cardiovascular Diabetology ·Valentina Spigoni, Federica Fantuzzi, Cecilia Carubbi, Giulia Pozzi, Elena Masselli, Giuliana Gobbi, Anna Solini, Riccardo C. Bonadonna, Alessandra Dei	49
8	255. Automated classification of Resting State fMRI networks using Machine Learning algorithms 2018 ·Physica Medica ·Chiara Pinardi, (unknown), Simona Gardini, (unknown), Mario Micheli, Valentina Spigoni, (unknown), C. Ghetti	2
9	Stearic acid at physiologic concentrations induces in vitro lipotoxicity in circulating angiogenic cells 2017 ·Atherosclerosis ·Valentina Spigoni, Federica Fantuzzi, (unknown), Monia Cito, Eleonora Derlindati, Ivana Zavaroni, Miriam Cnop, Riccardo C. Bonadonna, Alessandra Dei	21
10	Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects 2017 ·PLoS ONE ·(unknown), Eleonora Derlindati, Luca Marchetti, Valentina Spigoni, Alessandra Dei, Barbara Montanini, Diego Ardigò, Ivana Zavaroni, Corrado Priami, Riccardo C. Bonadonna	20
11	Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes 2017 ·Cardiovascular Diabetology ·Alessandra Dei, Valentina Spigoni, Monia Cito, Raffaella Aldigeri, (unknown), (unknown), Michela Marina, Eleonora Derlindati, Rosalia Aloe, Riccardo C. Bonadonna, Ivana Zavaroni	37
12	Novel insight into the dangerous connection between diabetes and heart failure 2016 ·Herz ·Carlo Lombardi, Valentina Spigoni, Elio Gorga, Alessandra Dei	14
13	Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study 2016 ·Acta Diabetologica ·Valentina Spigoni, Raffaella Aldigeri, (unknown), Eleonora Derlindati, Laura Franzini, (unknown), (unknown), Giovanni Battista Vigna, Ivana Zavaroni, Riccardo C. Bonadonna, Alessandra Dei	16
14	Effects on Nitric Oxide Production of Urolithins, Gut-Derived Ellagitannin Metabolites, in Human Aortic Endothelial Cells 2016 ·Molecules ·Valentina Spigoni, Pedro Mena, Monia Cito, Federica Fantuzzi, Riccardo C. Bonadonna, Furio Brighenti, Alessandra Dei, Daniele Del Rio	40
15	Transcriptomic Analysis of Human Polarized Macrophages: More than One Role of Alternative Activation? 2015 ·PLoS ONE ·Eleonora Derlindati, Alessandra Dei, Barbara Montanini, Valentina Spigoni, (unknown), Raffaella Aldigeri, Diego Ardigò, Ivana Zavaroni, Riccardo C. Bonadonna	57
16	Effects of TiO2 and Co3O4 Nanoparticles on Circulating Angiogenic Cells 2015 ·PLoS ONE ·Valentina Spigoni, Monia Cito, Rossella Alinovi, Silvana Pinelli, Giovanni Passeri, Ivana Zavaroni, Matteo Goldoni, Marco Campanini, Irene Aliatis, Antonio Mutti, Riccardo C. Bonadonna, Alessandra Dei	21
17	N-3 PUFA increase bioavailability and function of endothelial progenitor cells 2014 ·Food & Function ·Valentina Spigoni, Carlo Lombardi, Monia Cito, (unknown), (unknown), Roberta Andreoli, (unknown), Luigi Gnudi, Matteo Goldoni, Ivana Zavaroni, Riccardo Raddino, Alessandra Dei	26
18	Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance 2012 ·PLoS ONE ·Valentina Spigoni, (unknown), Monia Cito, (unknown), Sabrina Bonomini, (unknown), Ivana Zavaroni, Luigi Gnudi, Marco Metra, Alessandra Dei	38
19	Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy young adults 2011 ·Nutrition Metabolism and Cardiovascular Diseases ·Alessandra Dei, Valentina Spigoni, Laura Franzini, Milena Preti, Diego Ardigò, Eleonora Derlindati, Marco Metra, Lucilla D. Monti, Patrizia Dell’Era, Luigi Gnudi, Ivana Zavaroni	34
20	Reduced circulating endothelial progenitor cell number in healthy young adult hyperinsulinemic men 2010 ·Nutrition Metabolism and Cardiovascular Diseases ·Alessandra Dei, Valentina Spigoni, Diego Ardigò, Giuseppe Pedrazzi, Laura Franzini, Eleonora Derlindati, Serena Urbani, Lucilla D. Monti, Luigi Gnudi, Ivana Zavaroni	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact